| Literature DB >> 18259169 |
Michael J Russo1, David Balekdjian.
Abstract
The emergent healthcare value era, its consequences, and what drug firms need to do about it.Mesh：
Substances：
Year: 2008 PMID： 18259169 DOI： 10.1038/nbt0208-173
Source DB: PubMed Journal: Nat Biotechnol ISSN： 1087-0156 Impact factor: 54.908